EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

The Impact of Caesarean Delivery on Paracetamol and Ketorolac Pharmacokinetics: A Paired Analysis

Aida Kulo, Kristel van Calsteren, Rene Verbesselt, Anne Smits, Roland Devlieger, Jan de Hoon, Karel Allegaert

Journal of Biomedicine and Biotechnology · 2012 · 2012 · 1-5

DOI: 10.1155/2012/437639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedicine and Biotechnology, 2012. Verfasst von Aida Kulo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Pharmacology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Cesarean Section. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: JoinEU-SEE, Fund for Scientific Research, Belgium, Fundamental Clinical Investigatorship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacokinetics is a first, but essential step to improve population-tailored postoperative analgesia, also after Caesarean delivery. We therefore aimed to quantify the impact of caesarean delivery on the pharmacokinetics of intravenous (iv) paracetamol (2 g, single dose) and iv ketorolac tromethamine (30 mg, single dose) in 2 cohorts eachof 8 women at caesarean delivery and to compare these findings with postpartum to quantify intrapatient changes. We documented a higher median paracetamol clearance at delivery when compared to 10–15 weeks postpartum (11.7 to 6.4 L/h⋅m 2 , P < 0.01 ), even after correction for weight-related changes. Similar conclusions were drawn for ketorolac: median clearance was higher at delivery with a subsequent decrease (2.03 to 1.43 L/h⋅m 2 , P < 0.05 ) in postpartum (17–23 weeks). These differences likely reflect pregnancy- and caesarean-delivery-related changes in drug disposition. Moreover, postpartum paracetamol clearance was significantly lower when compared to estimates published in healthy young volunteers (6.4 versus 9.6 L/h⋅m 2 ), while this was not the case for ketorolac (1.43 versus 1.48 L/h⋅m 2 ). This suggests that postpartum is another specific status in young women that merits focused, compound-specific pharmacokinetic evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cesarean SectionAcetaminophenAnalgesia, ObstetricalAnalgesics, Non-NarcoticAnesthesia, ObstetricalAnti-Inflammatory Agents, Non-SteroidalArea Under CurveCohort StudiesFemaleHumansInjections, IntravenousKetorolacPregnancy

Substanzen

Analgesics, Non-NarcoticAnti-Inflammatory Agents, Non-SteroidalAcetaminophenKetorolac

Autor:innen und Institutionen

  • Center for Clinical Pharmacology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.

Förderung

  • JoinEU-SEE
  • Fund for Scientific Research, Belgium
  • Fundamental Clinical Investigatorship

Zitieren

APA

Kulo, A., van Calsteren, K., Verbesselt, R., Smits, A., Devlieger, R., de Hoon, J., & Allegaert, K. (2012). The Impact of Caesarean Delivery on Paracetamol and Ketorolac Pharmacokinetics: A Paired Analysis. Journal of Biomedicine and Biotechnology, 2012, 1-5. https://doi.org/10.1155/2012/437639

Vancouver

Kulo A, van Calsteren K, Verbesselt R, Smits A, Devlieger R, de Hoon J, et al. The Impact of Caesarean Delivery on Paracetamol and Ketorolac Pharmacokinetics: A Paired Analysis. Journal of Biomedicine and Biotechnology. 2012;2012:1-5. doi:10.1155/2012/437639

BibTeX
@article{Kulo2012,
  author = {Kulo, Aida and van Calsteren, Kristel and Verbesselt, Rene and Smits, Anne and Devlieger, Roland and de Hoon, Jan and Allegaert, Karel},
  title = {The Impact of Caesarean Delivery on Paracetamol and Ketorolac Pharmacokinetics: A Paired Analysis},
  journal = {Journal of Biomedicine and Biotechnology},
  year = {2012},
  volume = {2012},
  pages = {1--5},
  doi = {10.1155/2012/437639}
}
Kostenlos starten →